Pasternak Andy

CIK 00017927463 companiesPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001792746

Recent Transactions

50 trades

Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2026-06-24+45,000→ 45,000 total
Award
Kardigan, Inc.$KARD
Common Stock
2026-06-17+79,640→ 79,640 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2025-06-12+138,900→ 138,900 total
Award
Context Therapeutics Inc.$CNTX
Stock Option (right to buy)
2025-01-13+20,685→ 20,685 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−22,997→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,749→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−11,643→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−15,870→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−15,281→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−56,338→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−34,928→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,761→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−14,282→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,816→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−23,806→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−11,499→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,749→ 0 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-17$113.03/sh−27,129→ 56,338 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2023-01-04+22,997→ 22,997 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−14,514→ 0 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-30$113.80/sh−39,313→ 83,467 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−8,709→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−5,800→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−11,648→ 5,816 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−11,643→ 11,643 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−26,124→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSU)
2022-12-30−2,360→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-12-30−7,935→ 15,870 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-30+88,733→ 122,780 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+17,464→ 17,464 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+26,124→ 26,124 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-13$112.61/sh−23,251→ 40,965 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-13$112.60/sh−6,918→ 34,047 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-13$29.52/sh+23,251→ 64,216 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2022-12-13−23,251→ 0 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-11-01$63.18/sh−5,503→ 40,965 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-11-01+12,421→ 46,468 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2022-11-01+12,421→ 0 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-07-29$83.45/sh−643→ 34,047 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-07-29$82.44/sh−4,207→ 34,690 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-06-10$85.36/sh−762→ 38,897 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-02-18$94.82/sh−1,313→ 39,659 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-06$100.23/sh−349→ 40,972 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-06$99.85/sh−6,438→ 41,321 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-06$97.30/sh−500→ 48,459 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-01-06$98.33/sh−700→ 47,759 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−11,642→ 23,286 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−11,616→ 5,800 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−14,514→ 14,514 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2022-01-05−11,067→ 11,069 total

Companies

Recent Filings

Address

2001 MARKET STREET SUITE 3915 UNIT #15

PHILADELPHIA, PA, 19103

View on SEC.gov